David M. Blank, Partner

Publications and Presentations

Brenda M. Maloney ShaferBrenda M. Maloney Shafer
"To Be or Not to 340B: HHS Issues Advisory Opinion and New GAO Report Sheds Light on HRSA’s Enforcement Pullback"Pratt's Government Contracting Law ReportBy: Brenda M. Maloney Shafer, Richard B. Davis, David M. BlankMany drug manufacturers have decided that the Health Resources and Services Administration’s Office of Pharmacy Affairs guidance on contract pharmacy arrangements is no longer binding. Accordingly, some have curtailed selling 340B-priced drugs based on contract pharmacy encounters, causing a significant... Read More
Article "OIG Proposed Revisions to AKS Safe Harbor Rules: Implications for Life Sciences Stakeholders" American Health Lawyers Association (AHLA) David M. Blank
"Enforcement Rx: An Overview of Recent Government Actions Target Fraud, Waste, And Abuse in the Pharmacy Sector" Quarles & Brady Pharmacy Law Symposium
Presentation "False Claims Act Trends Impacting Organizational Compliance" Quarles & Brady Seminar David Blank
Presentation "Fraud and Abuse in the Managed Care Setting" AmeriHealth Caritas David M. Blank